For Immediate Release
May 18, 2007

 BUFFALO, NY- Bruce A. Chabner, MD, Clinical Director, Massachusetts General Hospital Cancer Center, will present the Alexander Bloch Memorial Lecture, Wednesday, May 23, at 8 am, in the David C. Hohn, MD Lecture Hall, Research Studies Center, Roswell Park Cancer Institute (RPCI), Elm & Carlton Streets, Buffalo, NY. The lecture is open to the public.

Dr. Chabner’s topic will be “Phase I-II Trials: The Value of Biomarkers.” He will discuss the objectives of Phase I and II clinical trials; the role of biomarkers in these studies; and methods to identify and remove barriers to the effective use of biomarkers in research studies.

Dr. Chabner’s research interests center in the clinical testing, pharmacokinetics and biochemical pharmacology of new anticancer drugs, particularly natural products and signal transduction inhibitors.

The Alexander Bloch Memorial Lecture was established to honor Dr. Bloch’s distinguished career as a cancer researcher and his seminal contributions to the understanding of anticancer drugs, some of which are now used as standard therapies. Dr. Block retired from Roswell Park in 2002 after 40 years of dedicated service.

Roswell Park Cancer Institute, founded in 1898, is the nation’s first cancer research, treatment and education center and is the only National Cancer Institute-designated comprehensive cancer center in Upstate New York. RPCI is a member of the prestigious National Comprehensive Cancer Network, an alliance of the nation’s leading cancer centers. Roswell Park has affiliate sites and collaborative programs in New York, Pennsylvania, and in China. For more information, visit RPCI’s website at www.roswellpark.org, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.

-30-